The last decade has witnessed a multistep evolution in the understanding of the natural
history, clinical manifestations, and some of the molecular mechanisms that underlie the …

Allogeneic stem cell transplantation (SCT) plays a central role in chronic myeloid leukemia
(CML) because it remains the only treatment with proven curative potential. For this reason …

Reduced-intensity conditioned (RIC) hematopoietic stem cell transplantation (HSCT) has
improved the accessibility of transplantation in patients previously ineligible. We report the …

We compared the results of chimerism analyses with real‐time SNP‐PCR to those obtained
by the classical STR‐PCR method in 135 hematopoietic stem cell transplantation recipients …

Although quantitative PCR (qPCR) has been explored for chimerism monitoring after
allogeneic stem cell transplantation (SCT), evidence regarding its clinical utility compared …

Outcomes of highly purified CD34+ peripheral blood stem cell transplantation (PBSCT) for
chronic phase chronic myeloid leukemia (CML)(n= 32) were compared with those of PBSCT …

Atypical chronic myeloid leukemia (aCML) occurs rarely and is associated with a poor
prognosis when treated with conventional chemotherapy. We evaluated the outcome of …

Myelofibrosis, either de novo or following pre-existing hematologic diseases, can be cured
by allogeneic hematopoietic stem cell transplantation (SCT), but SCT is associated with …

Persuasive evidence has been recently provided that adult bone marrow (BM) cells exert
greater plasticity than previously assumed. This review is focused on the quantification of …

Background Increasingly, clinicians advocate the use of nonmyeloablative allogeneic stem-
cell transplants (NM-allo-SCTs,“mini-transplants”) to manage hematologic malignancies …